Arrowpoint Asset Management »

Cymabay Therapeutics shares owned by Arrowpoint Asset Management

Quarter-by-quarter ownership of Cymabay Therapeutics shares owned by Arrowpoint Asset Management from 13F filings

Historical chart of Arrowpoint Asset Management investment in Cymabay Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cymabay Therapeutics held by Arrowpoint Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cymabay Therapeutics by Arrowpoint Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.2M 179k 23.62
2023-09-30 $2.7M 179k 14.91

More positions owned by Arrowpoint Asset Management

Rb Global (RBA)
Trimble Navigation (TRMB)
Alight Com Cl A (ALIT)
Acv Auctions Com Cl A (ACVA)
Matson (MATX)
J Global (ZD)
Sensata Technologies Hldg Pl SHS (ST)
Euronet Worldwide (EEFT)
Cargurus Com Cl A (CARG)
Steris Shs Usd (STE)
Merit Medical Systems (MMSI)
Churchill Downs (CHDN)
Okta Cl A (OKTA)
Cooper Cos (COO)
Smartsheet Com Cl A (SMAR)

View all positions for Arrowpoint Asset Management

Top funds holding Cymabay Therapeutics

venBio Select Advisor
Nicholas Investments Partners
Alliancebernstein
Wellington Management Company
Algert Coldiron Investors
ALPS Advisors
MetLife Investment Advisors
American International
Golden State Equity Partners
Healthcare Of Ontario Pension Plan Trust Fund
Metropolitan Life Insurance Company
Tucker Asset Management
EverSource Wealth Advisors
IFP Advisors
Able Wealth Management

View all funds holding Cymabay Therapeutics